These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17660718)

  • 21. Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016.
    Soeters HM; Dinitz-Sklar J; Kulkarni PA; MacNeil JR; McNamara LA; Zaremski E; Chang HY; Lujan E; Granoff D; Lasky M; Montana B
    Emerg Infect Dis; 2017 May; 23(5):867-869. PubMed ID: 28418307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine.
    Fu C; Huang G; Cui M; Wang M
    Hum Vaccin Immunother; 2014; 10(1):138-9. PubMed ID: 24013384
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances towards the prevention of meningococcal B disease: a multidimensional story.
    Roderick M; Finn A
    J Infect; 2014 Jan; 68 Suppl 1():S76-82. PubMed ID: 24139188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Princeton University can import vaccine to combat meningitis outbreak.
    Clin Infect Dis; 2014 Feb; 58(3):i. PubMed ID: 24571006
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.
    Holst J; Oster P; Arnold R; Tatley MV; Næss LM; Aaberge IS; Galloway Y; McNicholas A; O'Hallahan J; Rosenqvist E; Black S
    Hum Vaccin Immunother; 2013 Jun; 9(6):1241-53. PubMed ID: 23857274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococcal serogroup B infections: a search for a broadly protective vaccine.
    Vermont CL; van den Dobbelsteen GP
    Expert Rev Vaccines; 2003 Oct; 2(5):673-81. PubMed ID: 14711328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The next chapter for group B meningococcal vaccines.
    Wang NY; Pollard AJ
    Crit Rev Microbiol; 2018 Feb; 44(1):95-111. PubMed ID: 28557577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.
    Whelan J; Bambini S; Biolchi A; Brunelli B; Robert-Du Ry van Beest Holle M
    Expert Rev Vaccines; 2015 May; 14(5):713-36. PubMed ID: 25603916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
    Beeslaar J; Absalon J; Balmer P; Srivastava A; Maansson R; York LJ; Perez JL
    Vaccine; 2018 Jun; 36(28):4004-4013. PubMed ID: 29861182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.
    Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV
    Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines.
    Sandbu S; Feiring B; Oster P; Helland OS; Bakke HS; Naess LM; Aase A; Aaberge IS; Kristoffersen AC; Rydland KM; Tilman S; Nøkleby H; Rosenqvist E
    Clin Vaccine Immunol; 2007 Sep; 14(9):1062-9. PubMed ID: 17634513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunisation against meningococcus B.
    Blewitt J
    Lancet; 2013 Sep; 382(9895):857-8. PubMed ID: 24012267
    [No Abstract]   [Full Text] [Related]  

  • 33. A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?
    Martin NG; Snape MD
    Expert Rev Vaccines; 2013 Aug; 12(8):837-58. PubMed ID: 23984957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand.
    Oster P; O'Hallahan J; Aaberge I; Tilman S; Ypma E; Martin D
    Vaccine; 2007 Apr; 25(16):3075-9. PubMed ID: 17289223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of meningococcal disease in a schoolgirl previously given meningococcal C vaccine.
    Pugh RN; Heseltine A
    Commun Dis Public Health; 2002 Mar; 5(1):74. PubMed ID: 12070983
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal B Vaccination (4CMenB) in Infants and Toddlers.
    Esposito S; Tagliabue C; Bosis S
    J Immunol Res; 2015; 2015():402381. PubMed ID: 26351647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The legacy of MeNZB and possible implications for COVID-19 vaccination.
    Reid JS
    N Z Med J; 2020 Nov; 133(1525):114-118. PubMed ID: 33223554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand.
    Stehr-Green P; Radke S; Kieft C; Galloway Y; McNicholas A; Reid S
    Vaccine; 2008 Feb; 26(6):739-42. PubMed ID: 18187240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease.
    O'Hallahan J; McNicholas A; Galloway Y; O'Leary E; Roseveare C
    N Z Med J; 2009 Mar; 122(1291):48-59. PubMed ID: 19322255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Authors' response: Meningococcal vaccine antigen diversity in global databases.
    Brehony C; Hill DM; Lucidarme J; Borrow R; Maiden MC
    Euro Surveill; 2016 Apr; 21(15):. PubMed ID: 27104935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.